Trial · NCT07058636
Efficacy of Adding Greater Occipital Nerve Block to Trigger Point Injection in Patients With Neck Pain
NCT07058636, Not applicable, Recruiting, Ankara Etlik City Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Efficacy of Adding Greater Occipital Nerve Block to Trigger Point Injection in Patients With Neck Pain. Trials, record NCT07058636. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07058636
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Efficacy of Adding Greater Occipital Nerve Block to Trigger Point Injection in Patients With Neck Pain
- NCT number
- NCT07058636
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 60 participants, estimated
- Lead sponsor
- Ankara Etlik City Hospital
- Conditions
- Neck Pain, Myofacial Pain Syndrome, Trigger Point Pain, Myofascial, Trigger Points, Upper Trapezius Trigger Points, Cervicogenic Headache
- Interventions
- 2% Lidocaine HCl + saline, Steroid+lidocaine
- First posted
- 2025-07-10
- Last updated
- 2025-07-10
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Visual Analog Scale (VAS) | Baseline, Week 1 and Week 4 post-intervention. | Global pain assessment using a Visual Analog Scale ranging from 0 ("no pain") to 10 ("unbearable pain"). Patients rate their pain intensity on this scale. |
| Secondary | McGill-Melzack Pain Questionnaire | Baseline, Week 1 and Week 4 post-intervention. | A tool assessing qualitative and quantitative aspects of pain, including sensory, affective, and overall pain components. |
| Secondary | Neck Disability Index (NDI) | Baseline, Week 1, and Week 4 post-intervention. | A 10-item questionnaire evaluating functional limitations and disability caused by neck pain in daily activities. |
| Secondary | Nottingham Health Profile (NHP) | Baseline, Week 1 and Week 4 post-intervention. | A patient-reported questionnaire measuring subjective health status and quality of life across six dimensions: energy, pain, emotional reactions, sleep, social isolation, and physical mobility. |
| Secondary | Cervical Joint Position Error Test (Proprioception Assessment) | Baseline, Week 1 and Week 4 post-intervention. | Measurement of cervical proprioception errors during head and neck movements using a laser pointer and target board system. The average error in centimeters over six repetitions per movement will be recorded. |
| Secondary | Cervical Range of Motion (CROM) Measurement | Baseline, Week 1 and Week 4 post-intervention. | Objective measurement of cervical spine active range of motion in degrees using a goniometer. |
| Other | Craniovertebral Angle Measurement | Baseline only | Assessment of forward head posture using photogrammetric measurement of the craniovertebral angle. The angle is formed between a horizontal line passing through the C7 spinous process and a line connecting the tragus of the ear to C7. Smaller angles indicate a more pronounced forward head posture. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07058636
GET https://conductscience.org/api/trials/v1/NCT07058636/registered